Medicinova, Inc., Adelaware Corporation v. Genzyme Corporation, Amassachusetts Corporation

NOTE: This disposition is nonprecedential.

United States Court of Appeals
for the Federal Circuit
______________________

MEDICINOVA, INC., A DELAWARE
CORPORATION,
Plaintiff-Appellant

v.

GENZYME CORPORATION, A MASSACHUSETTS
CORPORATION,
Defendant-Appellee
______________________

2020-1064
______________________

Appeal from the United States District Court for the
Southern District of California in No. 3:14-cv-02513-JLS-
KSC, Judge Janis L. Sammartino.
______________________

JUDGMENT
______________________

B
RUCE G. CHAPMAN, Sheppard, Mullin, Richter &
Hampton LLP, Los Angeles, CA, argued for plaintiff-appel-
lant. Also represented by D
ON PELTO, Washington, DC;
MATTHEW G. HALGREN, MARK GERARD RACKERS, San Diego,
CA.

FRANCIS DIGIOVANNI, Faegre Drinker Biddle & Reath
LLP, Wilmington, DE, argued for defendant-appellee. Also
Case: 20-1064 Document: 70 Page: 1 Filed: 12/14/2020

represented by MICHAEL CURT LAMBERT, THATCHER A.
RAHMEIER; RABIYA KADER, Sanofi, Bridgewater, NJ.
______________________

T
HIS CAUSE having been heard and considered, it is

O
RDERED and ADJUDGED:

PER CURIAM (DYK, BRYSON, and O’MALLEY, Circuit
Judges).
AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 14, 2020
Date
/s/ Peter R. Marksteiner
Peter R. Marksteiner
Clerk of Court

Case: 20-1064 Document: 70 Page: 2 Filed: 12/14/2020